Literature DB >> 12594581

Peripartum cardiomyopathy: a condition intensivists should be aware of.

Esther de Beus1, Walther N K A van Mook, Graham Ramsay, Jan L M Stappers, Hans W H M van der Putten.   

Abstract

We use an illustrative case of severe peripartum cardiomyopathy with congestive heart failure to introduce this topic and proceed to cover its pathophysiology, incidence, management and outcome.

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12594581     DOI： 10.1007/s00134-002-1583-0

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


  72 in total

Review 1.  Carvedilol.

Authors:  W H Frishman
Journal:  N Engl J Med       Date:  1998-12-10       Impact factor: 91.245

2.  Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure.

Authors:  L Gullestad; P Aukrust; T Ueland; T Espevik; G Yee; R Vagelos; S S Frøland; M Fowler
Journal:  J Am Coll Cardiol       Date:  1999-12       Impact factor: 24.094

3.  Cerebral embolism as the initial manifestation of peripartum cardiomyopathy.

Authors:  M T Hodgman; M S Pessin; D C Homans; W Panis; R J Prager; E S Lathi; M G Criscitiello
Journal:  Neurology       Date:  1982-06       Impact factor: 9.910

4.  Intravenous immune globulin in the therapy of peripartum cardiomyopathy.

Authors:  B Bozkurt; F S Villaneuva; R Holubkov; T Tokarczyk; R J Alvarez; G A MacGowan; S Murali; W D Rosenblum; A M Feldman; D M McNamara
Journal:  J Am Coll Cardiol       Date:  1999-07       Impact factor: 24.094

5.  Effect of amlodipine on morbidity and mortality in severe chronic heart failure. Prospective Randomized Amlodipine Survival Evaluation Study Group.

Authors:  M Packer; C M O'Connor; J K Ghali; M L Pressler; P E Carson; R N Belkin; A B Miller; G W Neuberg; D Frid; J H Wertheimer; A B Cropp; D L DeMets
Journal:  N Engl J Med       Date:  1996-10-10       Impact factor: 91.245

6.  Peripartum heart failure associated with prolonged tocolytic therapy.

Authors:  M B Lampert; J Hibbard; L Weinert; J Briller; M Lindheimer; R M Lang
Journal:  Am J Obstet Gynecol       Date:  1993-02       Impact factor: 8.661

Review 7.  Clinical management of gravid women with peripartum cardiomyopathy.

Authors:  W Lee
Journal:  Obstet Gynecol Clin North Am       Date:  1991-06       Impact factor: 2.844

8.  Longitudinal changes in left ventricular architecture and function in peripartum cardiomyopathy.

Authors:  P Cole; F Cook; T Plappert; D Saltzman; M St John Sutton
Journal:  Am J Cardiol       Date:  1987-10-01       Impact factor: 2.778

9.  Peripartum cardiomyopathy: clinical, hemodynamic, histologic and prognostic characteristics.

Authors:  J B O'Connell; M R Costanzo-Nordin; R Subramanian; J A Robinson; D E Wallis; P J Scanlon; R M Gunnar
Journal:  J Am Coll Cardiol       Date:  1986-07       Impact factor: 24.094

10.  Peripartum cardiomyopathy: echocardiographic features in five cases.

Authors:  C Aroney; F Khafagi; C Boyle; N Bett
Journal:  Am J Obstet Gynecol       Date:  1986-07       Impact factor: 8.661
View more
  4 in total

Review 1.  [Cardiopulmonary emergencies during pregnancy and the postpartum period].

Authors:  M Rosenberg; N Frey
Journal:  Med Klin Intensivmed Notfmed       Date:  2012-02-10       Impact factor: 0.840

2.  [Heart diseases in pregnancy].

Authors:  Vera Regitz-Zagrosek; Christa Gohlke-Bärwolf; Annette Geibel-Zehender; Markus Haass; Harald Kaemmerer; Irmtraut Kruck; Christoph Nienaber
Journal:  Clin Res Cardiol       Date:  2008-09       Impact factor: 5.460

3.  A serious complication in the puerperium: peripartum cardiomyopathy.

Authors:  M G E Bosch; J G Santema; P H J van der Voort; J L Bams
Journal:  Neth Heart J       Date:  2008-12       Impact factor: 2.380

4.  Obstetric intensive care unit admission: a 2-year nationwide population-based cohort study.

Authors:  Joost J Zwart; Just R O Dupuis; Annemiek Richters; Ferko Ory; Jos van Roosmalen
Journal:  Intensive Care Med       Date:  2009-11-10       Impact factor: 17.440
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.